TreeWAS – Variant ID: rs17817600

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D24 Benign neoplasm of breast	0.073	0.927	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.058	0.942	0.000
T39.1 4-Aminophenol derivatives	0.055	0.945	0.000
T39.0 Salicylates	0.055	0.945	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.054	0.946	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.051	0.949	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.050	0.950	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.048	0.952	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.046	0.954	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.044	0.956	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.042	0.958	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.042	0.958	0.000
T39.4 Antirheumatics, not elsewhere classified	0.042	0.958	0.000
T39.2 Pyrazolone derivatives	0.042	0.958	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.042	0.958	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.042	0.958	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.041	0.959	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.041	0.959	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.041	0.959	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.039	0.961	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.039	0.961	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.039	0.961	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.039	0.961	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.039	0.961	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.039	0.961	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.037	0.963	0.000
T38.1 Thyroid hormones and substitutes	0.037	0.963	0.000
T36 Poisoning by systemic antibiotics	0.037	0.963	0.000
T43.9 Psychotropic drug, unspecified	0.037	0.963	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.037	0.963	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.037	0.963	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.036	0.964	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.036	0.964	0.000
T43.6 Psychostimulants with abuse potential	0.035	0.965	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.035	0.965	0.000
Z43.3 Attention to colostomy	0.034	0.966	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.034	0.966	0.000
T38.9 Other and unspecified hormone antagonists	0.033	0.966	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.033	0.966	0.000
T38.7 Androgens and anabolic congeners	0.033	0.966	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.033	0.966	0.000
T38.5 Other oestrogens and progestogens	0.033	0.966	0.000
T38.4 Oral contraceptives	0.033	0.966	0.000
T38.2 Antithyroid drugs	0.033	0.966	0.000
T38.0 Glucocorticoids and synthetic analogues	0.033	0.966	0.000
T43.2 Other and unspecified antidepressants	0.033	0.967	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.033	0.967	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.033	0.967	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.032	0.968	0.000
T46.1 Calcium-channel blockers	0.032	0.968	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.031	0.968	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.031	0.968	0.000
T46.7 Peripheral vasodilators	0.031	0.968	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.031	0.968	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.031	0.968	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.031	0.968	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.031	0.968	0.000
T42.0 Hydantoin derivatives	0.031	0.969	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.030	0.970	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.030	0.970	0.000
T42.3 Barbiturates	0.030	0.970	0.000
T42.2 Succinimides and oxazolidinediones	0.030	0.970	0.000
T50.8 Diagnostic agents	0.030	0.970	0.000
T50.7 Analeptics and opioid receptor antagonists	0.030	0.970	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.030	0.970	0.000
T50.5 Appetite depressants	0.030	0.970	0.000
T50.4 Drugs affecting uric acid metabolism	0.030	0.970	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.030	0.970	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.030	0.970	0.000
T50.1 Loop [high-ceiling] diuretics	0.030	0.970	0.000
T50.0 Mineralocorticoids and their antagonists	0.030	0.970	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.030	0.970	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.030	0.970	0.000
T47.7 Emetics	0.030	0.970	0.000
T47.6 Antidiarrhoeal drugs	0.030	0.970	0.000
T47.5 Digestants	0.030	0.970	0.000
T47.4 Other laxatives	0.030	0.970	0.000
T47.3 Saline and osmotic laxatives	0.030	0.970	0.000
T47.2 Stimulant laxatives	0.030	0.970	0.000
T47.0 Histamine H(2)-receptor antagonists	0.030	0.970	0.000
T42.4 Benzodiazepines	0.030	0.970	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.029	0.971	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.029	0.971	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.029	0.971	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.029	0.971	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.029	0.971	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.029	0.971	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.029	0.971	0.000
T44.0 Anticholinesterase agents	0.029	0.971	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.029	0.971	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.029	0.971	0.000
T40.6 Other and unspecified narcotics	0.028	0.972	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.028	0.972	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.028	0.972	0.000
T37.5 Antiviral drugs	0.028	0.972	0.000
T37.4 Anthelminthics	0.028	0.972	0.000
T37.3 Other antiprotozoal drugs	0.028	0.972	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.028	0.972	0.000
T37.1 Antimycobacterial drugs	0.028	0.972	0.000
T37.0 Sulphonamides	0.028	0.972	0.000
T41.5 Therapeutic gases	0.028	0.972	0.000
T41.4 Anaesthetic, unspecified	0.028	0.972	0.000
T41.3 Local anaesthetics	0.028	0.972	0.000
T41.2 Other and unspecified general anaesthetics	0.028	0.972	0.000
T41.1 Intravenous anaesthetics	0.028	0.972	0.000
T41.0 Inhaled anaesthetics	0.028	0.972	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.028	0.972	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.028	0.972	0.000
T48.5 Anti-common-cold drugs	0.028	0.972	0.000
T48.4 Expectorants	0.028	0.972	0.000
T48.3 Antitussives	0.028	0.972	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.028	0.972	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.028	0.972	0.000
T48.0 Oxytocic drugs	0.028	0.972	0.000
T49.9 Topical agent, unspecified	0.028	0.972	0.000
T49.8 Other topical agents	0.028	0.972	0.000
T49.7 Dental drugs, topically applied	0.028	0.972	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.028	0.972	0.000
T49.5 Ophthalmological drugs and preparations	0.028	0.972	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.028	0.972	0.000
T49.3 Emollients, demulcents and protectants	0.028	0.972	0.000
T49.2 Local astringents and local detergents	0.028	0.972	0.000
T49.1 Antipruritics	0.028	0.972	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.028	0.972	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.028	0.972	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.028	0.972	0.000
T42.1 Iminostilbenes	0.027	0.973	0.000
Z43 Attention to artificial openings	0.027	0.973	0.000
T36.9 Systemic antibiotic, unspecified	0.027	0.973	0.000
T36.8 Other systemic antibiotics	0.027	0.973	0.000
T36.7 Antifungal antibiotics, systemically used	0.027	0.973	0.000
T36.6 Rifamycins	0.027	0.973	0.000
T36.5 Aminoglycosides	0.027	0.973	0.000
T36.4 Tetracyclines	0.027	0.973	0.000
T36.3 Macrolides	0.027	0.973	0.000
T36.2 Chloramphenicol group	0.027	0.973	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.027	0.973	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.026	0.974	0.000
T45.8 Other primarily systemic and haematological agents	0.026	0.974	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.026	0.974	0.000
T45.6 Fibrinolysis-affecting drugs	0.026	0.974	0.000
T45.4 Iron and its compounds	0.026	0.974	0.000
T45.3 Enzymes, not elsewhere classified	0.026	0.974	0.000
T45.2 Vitamins, not elsewhere classified	0.026	0.974	0.000
T36.0 Penicillins	0.025	0.975	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.025	0.975	0.000
T40.8 Lysergide [LSD]	0.025	0.975	0.000
T40.7 Cannabis (derivatives)	0.025	0.975	0.000
T40.5 Cocaine	0.025	0.975	0.000
T40.3 Methadone	0.025	0.975	0.000
T40.1 Heroin	0.025	0.975	0.000
T40.0 Opium	0.025	0.975	0.000
T45.5 Anticoagulants	0.024	0.976	0.000
Z43.5 Attention to cyctostomy	0.024	0.976	0.000
T45.0 Antiallergic and antiemetic drugs	0.024	0.976	0.000
Z43.2 Attention to ileostomy	0.024	0.976	0.000
T40.4 Other synthetic narcotics	0.023	0.976	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.023	0.977	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.022	0.978	0.000
D45 Polycythaemia vera	0.022	0.978	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.021	0.979	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.021	0.979	0.000
Z43.1 Attention to gastrostomy	0.020	0.980	0.000
J84 Other interstitial pulmonary diseases	0.020	0.980	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.020	0.980	0.000
Z43.8 Attention to other artificial openings	0.020	0.980	0.000
Z43.0 Attention to tracheostomy	0.020	0.980	0.000
Z43.9 Attention to unspecified artificial opening	0.020	0.980	0.000
Z43.7 Attention to artificial vagina	0.020	0.980	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.019	0.981	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.018	0.982	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.018	0.982	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.018	0.982	0.000
D47.2 Monoclonal gammopathy	0.018	0.982	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.017	0.983	0.000
D48.0 Bone and articular cartilage	0.017	0.983	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.017	0.983	0.000
D46 Myelodysplastic syndromes	0.016	0.984	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.016	0.984	0.000
J84.8 Other specified interstitial pulmonary diseases	0.016	0.984	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.015	0.985	0.000
D38.1 Trachea, bronchus and lung	0.015	0.985	0.000
D48.4 Peritoneum	0.015	0.985	0.000
D44.0 Thyroid gland	0.015	0.985	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.015	0.985	0.000
J84.0 Alveolar and parietoalveolar conditions	0.015	0.985	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.015	0.985	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.015	0.985	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.015	0.985	0.000
D47.1 Chronic myeloproliferative disease	0.015	0.985	0.000
D38.5 Other respiratory organs	0.014	0.986	0.000
D44.1 Adrenal gland	0.014	0.986	0.000
D44.8 Pluriglandular involvement	0.014	0.986	0.000
D48.6 Breast	0.014	0.986	0.000
D44.6 Carotid body	0.014	0.986	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.014	0.986	0.000
D48.3 Retroperitoneum	0.014	0.986	0.000
D44.4 Craniopharyngeal duct	0.014	0.986	0.000
D47.4 Osteomyelofibrosis	0.014	0.986	0.000
D48.7 Other specified sites	0.013	0.986	0.000
T40.2 Other opioids	0.013	0.986	0.000
D48.1 Connective and other soft tissue	0.013	0.986	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.013	0.987	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.013	0.987	0.000
D38.6 Respiratory organ, unspecified	0.013	0.987	0.000
D38.4 Thymus	0.013	0.987	0.000
D38.3 Mediastinum	0.013	0.987	0.000
D38.2 Pleura	0.013	0.987	0.000
D44.9 Endocrine gland, unspecified	0.013	0.987	0.000
D44.7 Aortic body and other paraganglia	0.013	0.987	0.000
D44.5 Pineal gland	0.013	0.987	0.000
D44.2 Parathyroid gland	0.013	0.987	0.000
D38.0 Larynx	0.013	0.987	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.013	0.987	0.000
D46.7 Other myelodysplastic syndromes	0.012	0.988	0.000
D43.4 Spinal cord	0.012	0.988	0.000
K80.2 Calculus of gallbladder without cholecystitis	0.012	0.988	0.000
D43.1 Brain, infratentorial	0.012	0.988	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.012	0.988	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.012	0.988	0.000
D46.4 Refractory anaemia, unspecified	0.012	0.988	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.012	0.988	0.000
D46.1 Refractory anaemia with sideroblasts	0.012	0.988	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.012	0.988	0.000
D46.2 Refractory anaemia with excess of blasts	0.012	0.988	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.011	0.988	0.000
D43.0 Brain, supratentorial	0.011	0.989	0.000
D43.9 Central nervous system, unspecified	0.011	0.989	0.000
D43.7 Other parts of central nervous system	0.011	0.989	0.000
D43.3 Cranial nerves	0.011	0.989	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.011	0.989	0.000
D42.9 Meninges, unspecified	0.011	0.989	0.000
D42.1 Spinal meninges	0.011	0.989	0.000
D42.0 Cerebral meninges	0.011	0.989	0.000
D39.0 Uterus	0.011	0.989	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.011	0.989	0.000
Z36 Antenatal screening	0.011	0.989	0.000
D40.9 Male genital organ, unspecified	0.010	0.990	0.000
D40.7 Other male genital organs	0.010	0.990	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.010	0.990	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.010	0.990	0.000
D39.9 Female genital organ, unspecified	0.010	0.990	0.000
D39.7 Other female genital organs	0.010	0.990	0.000
D39.2 Placenta	0.010	0.990	0.000
D44.3 Pituitary gland	0.010	0.990	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.010	0.990	0.000
D37.7 Other digestive organs	0.010	0.990	0.000
D40.1 Testis	0.010	0.990	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.991	0.009
D41.2 Ureter	0.009	0.991	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.009	0.991	0.000
D43.2 Brain, unspecified	0.009	0.991	0.000
D41.0 Kidney	0.009	0.991	0.000
D37.9 Digestive organ, unspecified	0.009	0.991	0.000
D40.0 Prostate	0.008	0.991	0.000
D41.9 Urinary organ, unspecified	0.008	0.991	0.000
D41.7 Other urinary organs	0.008	0.991	0.000
D41.3 Urethra	0.008	0.991	0.000
D41.1 Renal pelvis	0.008	0.991	0.000
D37.3 Appendix	0.008	0.992	0.000
D37.0 Lip, oral cavity and pharynx	0.008	0.992	0.000
Z36.5 Antenatal screening for isoimmunisation	0.008	0.992	0.000
D37.2 Small intestine	0.008	0.992	0.000
C77.2 Intra-abdominal lymph nodes	0.000	0.992	0.008
Z36.9 Antenatal screening, unspecified	0.008	0.992	0.000
D37.1 Stomach	0.007	0.992	0.000
Z92.4 Personal history of major surgery, not elsewhere classified	0.007	0.993	0.000
M24.1 Other articular cartilage disorders	0.000	0.993	0.007
D48.5 Skin	0.006	0.993	0.000
D37.5 Rectum	0.007	0.993	0.000
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.000	0.993	0.006
D37.6 Liver, gallbladder and bile ducts	0.006	0.993	0.000
D39.1 Ovary	0.006	0.994	0.000
H43.3 Other vitreous opacities	0.000	0.994	0.006
M24.13 Other articular cartilage disorders (Forearm)	0.000	0.994	0.006
M47.87 Other spondylosis (Lumbosacral region)	0.005	0.995	0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.005	0.995	0.000
M24.19 Other articular cartilage disorders (Site unspecified)	0.000	0.995	0.005
M24.18 Other articular cartilage disorders (Other)	0.000	0.995	0.005
M24.14 Other articular cartilage disorders (Hand)	0.000	0.995	0.005
M24.12 Other articular cartilage disorders (Upper arm)	0.000	0.995	0.005
M24.10 Other articular cartilage disorders (Multiple sites)	0.000	0.995	0.005
M47.89 Other spondylosis (Site unspecified)	0.005	0.995	0.000
Z36.8 Other antenatal screening	0.005	0.995	0.000
M89.8 Other specified disorders of bone	0.005	0.995	0.000
M24.11 Other articular cartilage disorders (Shoulder region)	0.000	0.995	0.005
C85.7 Other specified types of non-Hodgkin's lymphoma	0.005	0.995	0.000
M89 Other disorders of bone	0.005	0.995	0.000
M24.17 Other articular cartilage disorders (Ankle and foot)	0.000	0.995	0.004
M89.9 Disorder of bone, unspecified	0.005	0.995	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.004	0.995	0.000
M47.8 Other spondylosis	0.005	0.995	0.000
C85.1 B-cell lymphoma, unspecified	0.004	0.996	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.004	0.996	0.000
T84.0 Mechanical complication of internal joint prosthesis	0.000	0.996	0.004
M89.96 Disorder of bone, unspecified (Lower leg)	0.004	0.996	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.004	0.996	0.000
H43 Disorders of vitreous body	0.000	0.996	0.004
D37.4 Colon	0.004	0.996	0.000
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.004	0.996	0.000
H43.8 Other disorders of vitreous body	0.000	0.996	0.004
M87.9 Osteonecrosis, unspecified	0.004	0.996	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.004	0.996	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.996	0.004
M89.84 Other specified disorders of bone (Hand)	0.004	0.996	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.004	0.996	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.004	0.996	0.000
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.004	0.996	0.000
Z82.0 Family history of epilepsy and other diseases of the nervous system	0.004	0.996	0.000
D75.1 Secondary polycythaemia	0.004	0.996	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.004	0.996	0.000
O63.1 Prolonged second stage (of labour)	0.004	0.996	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.004	0.996	0.000
H43.9 Disorder of vitreous body, unspecified	0.000	0.996	0.004
Z29.1 Prophylactic immunotherapy	0.004	0.996	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.004	0.996	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.004	0.996	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
C82.4 Follicular lymphoma grade IIIb	0.004	0.996	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.004	0.996	0.000
M89.88 Other specified disorders of bone (Other)	0.004	0.996	0.000
M89.83 Other specified disorders of bone (Forearm)	0.004	0.996	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.004	0.996	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.004	0.996	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.004	0.996	0.000
R70.0 Elevated erythrocyte sedimentation rate	0.004	0.996	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.004	0.996	0.000
J43.9 Emphysema, unspecified	0.004	0.996	0.000
M89.6 Osteopathy after poliomyelitis	0.003	0.996	0.000
M89.2 Other disorders of bone development and growth	0.003	0.996	0.000
M89.1 Epiphyseal arrest	0.003	0.996	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.003	0.996	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.003	0.996	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.003	0.996	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.003	0.996	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.003	0.996	0.000
M89.0 Algoneurodystrophy	0.003	0.996	0.000
M87.91 Osteonecrosis, unspecified (Shoulder region)	0.003	0.996	0.000
M89.98 Disorder of bone, unspecified (Other)	0.003	0.996	0.000
M89.3 Hypertrophy of bone	0.003	0.996	0.000
M47.84 Other spondylosis (Thoracic region)	0.003	0.996	0.000
M47.83 Other spondylosis (Cervicothoracic region)	0.003	0.996	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.003	0.996	0.000
M47.82 Other spondylosis (Cervical region)	0.003	0.997	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.003	0.997	0.000
C82.3 Follicular lymphoma grade IIIa	0.003	0.997	0.000
C82.2 Large cell, follicular	0.003	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
C85.0 Lymphosarcoma	0.003	0.997	0.000
M87 Osteonecrosis	0.003	0.997	0.000
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.003	0.997	0.000
M89.48 Other hypertrophic osteoarthropathy (Other)	0.003	0.997	0.000
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.003	0.997	0.000
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.003	0.997	0.000
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.003	0.997	0.000
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.003	0.997	0.000
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.003	0.997	0.000
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.003	0.997	0.000
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.003	0.997	0.000
H43.2 Crystalline deposits in vitreous body	0.000	0.997	0.003
Z11.0 Special screening examination for intestinal infectious diseases	0.000	0.997	0.003
H43.0 Vitreous prolapse	0.000	0.997	0.003
M48.02 Spinal stenosis (Cervical region)	0.003	0.997	0.000
R59.0 Localised enlarged lymph nodes	0.003	0.997	0.000
M87.99 Osteonecrosis, unspecified (Site unspecified)	0.003	0.997	0.000
M87.98 Osteonecrosis, unspecified (Other)	0.003	0.997	0.000
M87.97 Osteonecrosis, unspecified (Ankle and foot)	0.003	0.997	0.000
M87.96 Osteonecrosis, unspecified (Lower leg)	0.003	0.997	0.000
M87.94 Osteonecrosis, unspecified (Hand)	0.003	0.997	0.000
M87.93 Osteonecrosis, unspecified (Forearm)	0.003	0.997	0.000
M87.92 Osteonecrosis, unspecified (Upper arm)	0.003	0.997	0.000
M87.90 Osteonecrosis, unspecified (Multiple sites)	0.003	0.997	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.003	0.997	0.000
Z29.2 Other prophylactic chemotherapy	0.003	0.997	0.000
C78.7 Secondary malignant neoplasm of liver	0.000	0.997	0.003
C82.0 Small cleaved cell, follicular	0.003	0.997	0.000
C82.6 Cutaneous follicle centre lymphoma	0.003	0.997	0.000
C82.5 Diffuse follicle centre lymphoma	0.003	0.997	0.000
K80.4 Calculus of bile duct with cholecystitis	0.003	0.997	0.000
M89.5 Osteolysis	0.003	0.997	0.000
M86-M90 Other osteopathies	0.003	0.997	0.000
R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity	0.003	0.997	0.000
K80 Cholelithiasis	0.003	0.997	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.003	0.997	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.003	0.997	0.000
D09.0 Bladder	0.000	0.997	0.003
Z29 Need for other prophylactic measures	0.003	0.997	0.000
M89.19 Epiphyseal arrest (Site unspecified)	0.003	0.997	0.000
M89.18 Epiphyseal arrest (Other)	0.003	0.997	0.000
M89.17 Epiphyseal arrest (Ankle and foot)	0.003	0.997	0.000
M89.16 Epiphyseal arrest (Lower leg)	0.003	0.997	0.000
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.003	0.997	0.000
M89.14 Epiphyseal arrest (Hand)	0.003	0.997	0.000
M89.13 Epiphyseal arrest (Forearm)	0.003	0.997	0.000
M89.12 Epiphyseal arrest (Upper arm)	0.003	0.997	0.000
M89.11 Epiphyseal arrest (Shoulder region)	0.003	0.997	0.000
M89.10 Epiphyseal arrest (Multiple sites)	0.003	0.997	0.000
M89.29 Other disorders of bone development and growth (Site unspecified)	0.003	0.997	0.000
M89.28 Other disorders of bone development and growth (Other)	0.003	0.997	0.000
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.003	0.997	0.000
M89.26 Other disorders of bone development and growth (Lower leg)	0.003	0.997	0.000
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.003	0.997	0.000
M89.24 Other disorders of bone development and growth (Hand)	0.003	0.997	0.000
M89.23 Other disorders of bone development and growth (Forearm)	0.003	0.997	0.000
M89.22 Other disorders of bone development and growth (Upper arm)	0.003	0.997	0.000
M89.21 Other disorders of bone development and growth (Shoulder region)	0.003	0.997	0.000
M89.20 Other disorders of bone development and growth (Multiple sites)	0.003	0.997	0.000
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.003	0.997	0.000
M89.68 Osteopathy after poliomyelitis (Other)	0.003	0.997	0.000
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.003	0.997	0.000
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.003	0.997	0.000
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.003	0.997	0.000
M89.64 Osteopathy after poliomyelitis (Hand)	0.003	0.997	0.000
M89.63 Osteopathy after poliomyelitis (Forearm)	0.003	0.997	0.000
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.003	0.997	0.000
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.003	0.997	0.000
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.003	0.997	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
R70.1 Abnormal plasma viscosity	0.003	0.997	0.000
M89.08 Algoneurodystrophy (Other)	0.003	0.997	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.003	0.997	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.003	0.997	0.000
M89.03 Algoneurodystrophy (Forearm)	0.003	0.997	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.003	0.997	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.003	0.997	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.003	0.997	0.000
M89.39 Hypertrophy of bone (Site unspecified)	0.003	0.997	0.000
M89.38 Hypertrophy of bone (Other)	0.003	0.997	0.000
M89.36 Hypertrophy of bone (Lower leg)	0.003	0.997	0.000
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.003	0.997	0.000
M89.34 Hypertrophy of bone (Hand)	0.003	0.997	0.000
M89.33 Hypertrophy of bone (Forearm)	0.003	0.997	0.000
M89.32 Hypertrophy of bone (Upper arm)	0.003	0.997	0.000
M89.31 Hypertrophy of bone (Shoulder region)	0.003	0.997	0.000
M89.30 Hypertrophy of bone (Multiple sites)	0.003	0.997	0.000
R29.6 Tendency to fall, not elsewhere classified	0.003	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.003	0.997	0.000
M87.3 Other secondary osteonecrosis	0.003	0.997	0.000
M87.1 Osteonecrosis due to drugs	0.003	0.997	0.000
M87.0 Idiopathic aseptic necrosis of bone	0.003	0.997	0.000
Q21.1 Atrial septal defect	0.003	0.997	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.003	0.997	0.000
D72.8 Other specified disorders of white blood cells	0.003	0.997	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.003	0.997	0.000
M87.8 Other osteonecrosis	0.002	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.003	0.997	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.003	0.997	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.997	0.000
M89.59 Osteolysis (Site unspecified)	0.002	0.997	0.000
M89.58 Osteolysis (Other)	0.002	0.997	0.000
M89.57 Osteolysis (Ankle and foot)	0.002	0.997	0.000
M89.56 Osteolysis (Lower leg)	0.002	0.997	0.000
M89.54 Osteolysis (Hand)	0.002	0.997	0.000
M89.53 Osteolysis (Forearm)	0.002	0.997	0.000
M89.52 Osteolysis (Upper arm)	0.002	0.997	0.000
M89.51 Osteolysis (Shoulder region)	0.002	0.997	0.000
M89.50 Osteolysis (Multiple sites)	0.002	0.997	0.000
M87.2 Osteonecrosis due to previous trauma	0.002	0.997	0.000
M86 Osteomyelitis	0.002	0.997	0.000
M88 Paget's disease of bone [osteitis deformans]	0.002	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.002	0.997	0.000
J33.8 Other polyp of sinus	0.003	0.997	0.000
S70.9 Superficial injury of hip and thigh, unspecified	0.002	0.998	0.000
D41.4 Bladder	0.002	0.998	0.000
D75.8 Other specified diseases of blood and blood-forming organs	0.002	0.998	0.000
M24.8 Other specific joint derangements, not elsewhere classified	0.000	0.998	0.002
M24.87 Other specific joint derangements, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
K80.3 Calculus of bile duct with cholangitis	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
R82 Other abnormal findings in urine	0.000	0.998	0.002
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.002	0.998	0.000
M24 Other specific joint derangements	0.000	0.998	0.002
Z29.9 Prophylactic measure, unspecified	0.002	0.998	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
D75 Other diseases of blood and blood-forming organs	0.002	0.998	0.000
M24.86 Other specific joint derangements, not elsewhere classified (Lower leg)	0.000	0.998	0.002
M86.6 Other chronic osteomyelitis	0.002	0.998	0.000
R74.8 Abnormal levels of other serum enzymes	0.002	0.998	0.000
Z99.8 Dependence on other enabling machines and devices	0.002	0.998	0.000
M87.09 Idiopathic aseptic necrosis of bone (Site unspecified)	0.002	0.998	0.000
M87.08 Idiopathic aseptic necrosis of bone (Other)	0.002	0.998	0.000
M87.07 Idiopathic aseptic necrosis of bone (Ankle and foot)	0.002	0.998	0.000
M87.06 Idiopathic aseptic necrosis of bone (Lower leg)	0.002	0.998	0.000
M87.05 Idiopathic aseptic necrosis of bone (Pelvic region and thigh)	0.002	0.998	0.000
M87.04 Idiopathic aseptic necrosis of bone (Hand)	0.002	0.998	0.000
M87.03 Idiopathic aseptic necrosis of bone (Forearm)	0.002	0.998	0.000
M87.02 Idiopathic aseptic necrosis of bone (Upper arm)	0.002	0.998	0.000
M87.01 Idiopathic aseptic necrosis of bone (Shoulder region)	0.002	0.998	0.000
M87.00 Idiopathic aseptic necrosis of bone (Multiple sites)	0.002	0.998	0.000
M87.19 Osteonecrosis due to drugs (Site unspecified)	0.002	0.998	0.000
M87.18 Osteonecrosis due to drugs (Other)	0.002	0.998	0.000
M87.17 Osteonecrosis due to drugs (Ankle and foot)	0.002	0.998	0.000
M87.16 Osteonecrosis due to drugs (Lower leg)	0.002	0.998	0.000
M87.15 Osteonecrosis due to drugs (Pelvic region and thigh)	0.002	0.998	0.000
M87.14 Osteonecrosis due to drugs (Hand)	0.002	0.998	0.000
M87.13 Osteonecrosis due to drugs (Forearm)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations